Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: A multicenter trial
Identifieur interne : 00C967 ( Main/Exploration ); précédent : 00C966; suivant : 00C968Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: A multicenter trial
Auteurs : Donald M. Poretz [États-Unis]Source :
- The American Journal of Medicine [ 0002-9343 ] ; 1994.
Abstract
The purpose of this study was to examine the safety and efficacy of outpatient intravenous antibiotic therapy for skin and soft-tissue infections and determine its effect on length of hospital stay. In this open-label, multicenter, prospective study, 130 adult patients with skin and soft-tissue infections requiring parenteral antibiotic therapy were enrolled as a subgroup. Initial therapy was delivered to hospital impatients or in outpatient treatment centers, followed by home infusion therapy. Cefotaxime was delivered intravenously using a programmable ambulatory infusion pump. The clinical response rate was 97.5% (n = 118), while the bacteriologic response rate was 94.0% (n = 83). Only 32.2% of patients required hospitalization, and the mean duration of inpatient care for all evaluable patients was only 1.5 days. The mean duration of hospitalization for patients receiving inpatient care was 4.7 days. In conclusion, home intravenous cefotaxime therapy is safe, effective, and may reduce healthcare costs for many patients with skin and soft-tissue infections.
Url:
DOI: 10.1016/0002-9343(94)90284-4
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 005D30
- to stream Istex, to step Curation: 005D30
- to stream Istex, to step Checkpoint: 004A63
- to stream Main, to step Merge: 00D343
- to stream Main, to step Curation: 00C967
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: A multicenter trial</title><author><name sortKey="Poretz, Donald M" sort="Poretz, Donald M" uniqKey="Poretz D" first="Donald M." last="Poretz">Donald M. Poretz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C70C915F1BCB862C5A22D683EE87F8A043641C89</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1016/0002-9343(94)90284-4</idno><idno type="url">https://api.istex.fr/document/C70C915F1BCB862C5A22D683EE87F8A043641C89/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">005D30</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005D30</idno><idno type="wicri:Area/Istex/Curation">005D30</idno><idno type="wicri:Area/Istex/Checkpoint">004A63</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">004A63</idno><idno type="wicri:doubleKey">0002-9343:1994:Poretz D:treatment:of:skin</idno><idno type="wicri:Area/Main/Merge">00D343</idno><idno type="wicri:Area/Main/Curation">00C967</idno><idno type="wicri:Area/Main/Exploration">00C967</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: A multicenter trial</title><author><name sortKey="Poretz, Donald M" sort="Poretz, Donald M" uniqKey="Poretz D" first="Donald M." last="Poretz">Donald M. Poretz</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Infectious Diseases Physicians, Inc.</wicri:regionArea><wicri:noRegion>Inc.</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">The American Journal of Medicine</title><title level="j" type="abbrev">AJM</title><idno type="ISSN">0002-9343</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1994">1994</date><biblScope unit="volume">97</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="supplement">S1</biblScope><biblScope unit="page" from="23">23</biblScope><biblScope unit="page" to="27">27</biblScope></imprint><idno type="ISSN">0002-9343</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9343</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The purpose of this study was to examine the safety and efficacy of outpatient intravenous antibiotic therapy for skin and soft-tissue infections and determine its effect on length of hospital stay. In this open-label, multicenter, prospective study, 130 adult patients with skin and soft-tissue infections requiring parenteral antibiotic therapy were enrolled as a subgroup. Initial therapy was delivered to hospital impatients or in outpatient treatment centers, followed by home infusion therapy. Cefotaxime was delivered intravenously using a programmable ambulatory infusion pump. The clinical response rate was 97.5% (n = 118), while the bacteriologic response rate was 94.0% (n = 83). Only 32.2% of patients required hospitalization, and the mean duration of inpatient care for all evaluable patients was only 1.5 days. The mean duration of hospitalization for patients receiving inpatient care was 4.7 days. In conclusion, home intravenous cefotaxime therapy is safe, effective, and may reduce healthcare costs for many patients with skin and soft-tissue infections.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Poretz, Donald M" sort="Poretz, Donald M" uniqKey="Poretz D" first="Donald M." last="Poretz">Donald M. Poretz</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00C967 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00C967 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:C70C915F1BCB862C5A22D683EE87F8A043641C89
|texte= Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: A multicenter trial
}}
| This area was generated with Dilib version V0.6.31. |  |